Dronabinol-Acetazolamide Combination for Obstructive Sleep Apnea

Dronabinol-Acetazolamide Combination for Obstructive Sleep Apnea
$3.67IXHL last close Jun 15
77%66%55%Jun 8Jun 9Jun 10Jun 11Jun 12Jun 13Jun 14Jun 15Jun 16Jun 16 • YES 66.4%
Incannex Healthcare Ltd ($IXHL)
$3.67IXHL last close Jun 15
No stock close$3.99$3.66$3.32Jun 8Jun 9Jun 10Jun 11Jun 12Jun 13Jun 14Jun 15Jun 16Jun 8 • IXHL $3.40Jun 9 • IXHL $3.67Jun 10 • IXHL $3.91Jun 11 • IXHL $3.82Jun 12 • IXHL $3.83Jun 15 • IXHL $3.67

Will this trial show a positive result on change in apnea-hypopnea index (AHI), Phase 3?

Paper Trading
Create account to trade
Primary Completion
12/1/26
Study Completion
12/1/26
Sponsor
Incannex Healthcare Ltd
Ticker
$IXHL
Type
Phase 2/Phase 3
Trial Status
Active, not recruiting
Trial Size
560
NCT
NCT06146101
Trial Description
IHL-42X is being tested in adults with obstructive sleep apnea to reduce breathing interruptions during sleep.